. B and FSH concentration (r ϭ 0.49, P Ͻ 0.001) was
hypogonadotrophic men consistent with stimulation of inhibin secretion by FSH. Thus administration of gonadotrophin releas- 4 To whom correspondence should be addressed ing hormone (GnRH) increased inhibin concentrations in 5 Current address: Department of Obstetrics and Gynaecology, hypogonadotrophic men (Sheckter et al., 1988) , and FSH Monash University, Clayton,Victoria, Australia increased inhibin concentrations in normal men following Inhibin has been postulated to be secreted by Sertoli cells suppression of endogenous FSH by human chorionic gonadoin response to follicle stimulating hormone (FSH) and in trophin (HCG) administration . Androturn to exert an inhibitory effect on FSH production. We gen-or GnRH antagonist-induced gonadotrophin suppression have investigated this relationship using an assay specific resulted in a fall in inhibin concentrations (Bagatell et al., for dimeric inhibin B. A total of 56 normal men received 1989; Wallace et al., 1993) . Annual variations in inhibin 200 mg testosterone enanthate (TE) i.m. weekly, for 65 Ϯ concentrations have also been reported, increasing with lutein-1 weeks in a trial of hormonal male contraception. Before izing hormone (LH), FSH and testosterone in June with a treatment a significant negative correlation between inhibin nadir in August (Meriggiola et al., 1996) . B and FSH concentration (r ϭ 0.49, P Ͻ 0.001) was
Results from these studies were all obtained using a heteroobserved. During TE treatment, luteinizing hormone (LH) logous radioimmunoassay, which detects the biologically inactand FSH were rapidly suppressed. This was followed by a ive free α subunit as well as dimeric inhibins (Schneyer et al. , parallel decline in inhibin B and sperm concentration. 1990). New immunoassays which specifically detect only During the early recovery phase, inhibin B concentrations dimeric inhibins with negligible cross-reactivity with the free remained suppressed in men who showed a delay in α-subunit have recently been developed (Groome and O'Brien, resumption of spermatogenesis, despite higher FSH concen-1994), allowing reinvestigation of the roles of inhibin in the trations. Inhibin B returned to pretreatment concentrations control of FSH secretion and as a circulating marker of Sertoli after 24 weeks recovery, when the inverse relationship with cell function. Using these novel specific assays, it has recently FSH was restored. Our results showed the expected inverse been demonstrated that, unlike in the female, inhibin A is physiological relationship between inhibin B and FSH in undetectable in the plasma of normal men, and that there is normal men, with a decline during TE treatment and α an inverse relationship between plasma concentrations of subsequent resumption of the inverse relationship during inhibin B and FSH in normal men and in pathological recovery. These data clearly support the hypothesis that conditions (Anawalt et al., 1996; Illingworth et al., 1996 ; inhibin B plays a physiological role in the feedback control Nachtigall et al., 1996) . Inhibin B has therefore been suggested of FSH secretion, and reflects FSH-stimulated Sertoli cell to be the physiologically important form of inhibin in men.
function.
We here report investigations into the physiological relation- Fertility, 1996) . Of interest is the consistent finding that suppression of spermatogenesis α with either β A or β B (Burger and Igarashi, 1988) . Many molecular forms are found in the circulation, although biois not complete in all men, with~30% maintaining a low rate of sperm production despite undetectable gonadotrophin logical activity resides only in dimeric forms, inhibin A (αβ A ) and inhibin B (αβ B ). A physiological function for a nonsecretion (WHO Task Force on Methods for the Regulation of Male Fertility, 1995; Handelsman et al., 1995) . The basis for steroidal secretory product of the testis selectively to suppress biochemical screening and haematological analyses. On two occasions this heterogeneity is unknown, although differences in androbefore TE treatment was started, all subjects were confirmed to gen metabolism (Anderson et al., 1996) , and higher pretreathave sperm densities of Ͼ20ϫ10 6 /ml, and plasma concentrations of ment and recovery FSH concentrations (Handelsman et al., (Anawalt et al., 1996) . Since circulating duration of treatment was 65 Ϯ 1 weeks (range 53-80). Following inhibin is a Sertoli cell secretory product (Steinberger and the final TE injection, subjects were monitored until sperm concentra- Steinberger, 1976; Roberts et al., 1989; Vligen et al., 1993) , tion had returned to pretreatment values.
we have investigated the possibility that differences in the Semen samples were analysed according to WHO (1987) criteria after 3 days of ejaculatory abstinence at 2-4 week intervals throughout degree of suppression of spermatogenesis by TE are reflected the study. Azoospermia was confirmed by examination of the pellet in circulating concentrations of inhibin B.
after centrifugation.
Blood samples were obtained prior to the first injection, after 12
Materials and methods
weeks TE treatment, and on two occasions later, after 8-10 months and after 11-15 months of continued treatment. The recovery phase A total of 56 healthy caucasian men aged 21-41 years (mean 31 Ϯ was defined as starting 1 week after the final TE injection, and blood 2 SEM) were recruited to a multicentre clinical trial of hormonal and semen samples were taken after 12 and 24 weeks recovery. In α male contraception (WHO Task Force on Methods for the Regulation of Male Fertility, 1996) after routine medical examination and subgroup of 30 men additional blood samples were obtained 1, 2, 4, for repeated measures, or Student's t-test for single results. Correlation coefficients and statistical comparisons were performed on logtransformed data to correct for non-Gaussian distribution. The MannWhitney U-test was used for non-parametric data. Significance was determined at P Ͻ 0.05.
Results
Inhibin B was detectable in the plasma of all men pretreatment. The mean concentration of inhibin B in healthy normal subjects was 291 Ϯ 13 pg/ml. There was a significant inverse correlation between inhibin B and FSH concentrations pre-treatment (r ϭ -0.49, P Ͻ 0.001, Figure 1a ). There was no correlation between inhibin B and sperm concentration (r ϭ 0.19, ns, Figure 1b ), LH concentration (r ϭ 0.08, ns, Figure 1c ) or testosterone concentration (r ϭ 0.17, ns, Figure 1d ) at that time, but there was a positive correlation between LH and testosterone pretreatment (r ϭ 0.40, P Ͻ 0.01). During administration of TE there was a fall in inhibin B concentrations (P Ͻ 0.001, Figure 2 ). Inhibin B concentrations fell rapidly over the first 12 weeks, then continued to fall more slowly during prolonged TE administration, reaching a nadir of 100 Ϯ 6 pg/ml at the end of TE treatment. There was no relationship between duration of TE treatment and inhibin B concentration at the end of treatment. Following discontinuation of TE treatment, inhibin B concentration recovered to 202 Ϯ 20 pg/ml at 3 months and 253 Ϯ 21 pg/ml at 6 months, at which time it was not significantly different from pretreatment.
The more frequent blood sampling regimen of the subgroup The assay is a two-site enzyme-linked immunoassay, using plates azoospermic within 20 weeks of TE treatment at which time coated with antibody to the β B subunit, and a second antibody directed against the N-terminal portion of the α subunit, conjugated to alkaline the sperm concentration in the remaining, oligozoospermic, phosphatase, as previously described . The responders was 2.0 Ϯ 0.6ϫ10 6 /ml. There was, however, no monoclonal antibody was immobilized on a hydrazide plate, and difference in inhibin B concentrations pretreatment or during prior to assay all samples were treated at 100°C to eliminate non-TE treatment between these two groups (Table I ). Thus inhibin specific binding then treated with 2% hydrogen peroxide for 30 min.
B concentrations continued to fall for the duration of TE
The assay has Ͻ0.1% cross-reactivity with activin forms, and Ͻ0.5% treatment in those 15 men who rapidly achieved azoospermia, with inhibin A. Assay sensitivity was 10 pg/ml. Inter-and intra-plate concentrations being at all time points similar to those who coefficients of variation were Ͻ7 and Ͻ5% respectively. maintained a low rate of spermatogenesis. Sperm concentration
Other assays
continued to fall in the oligozoospermic responders, and by Plasma testosterone was measured by previously-described radiothe end of TE treatment spermatozoa were detectable only in immunoassay (Corker and Davidson, 1978 Values are means Ϯ SEM, n ϭ 30. There was a significant (*P Ͻ 0.001) difference in sperm concentration between azoospermic versus oligozoospermic responders during TE treatment but not pretreatment, and no difference in inhibin B concentrations between the two groups at any time-point. the recovery phase (Table II) . Thus 11 of the 30 men remained (3.8 Ϯ 0.3 IU/l pretreatment, 3.3 Ϯ 0.3 IU/l after 24 weeks recovery). At this time, a significant inverse correlation between azoospermic after 8 weeks (group A), at which time the mean sperm concentration in the other 19 men (group B) was 11 Ϯ inhibin B concentration and FSH concentration was again found (r ϭ 0.45, P Ͻ 0.02). 5ϫ10 6 /ml. The duration of TE treatment did not differ between these two groups: 62 Ϯ 2 weeks in group A versus 63 Ϯ 3 weeks in group B. Group B showed a slower suppression of Discussion spermatogenesis, reaching a threshold of 5ϫ10 6 /ml after 9.2 Ϯ 0.8 weeks compared to 5.2 Ϯ 0.8 weeks in group A (P ϭ Our results demonstrate a significant inverse relationship between plasma inhibin B and FSH in normal men under 0.001). There were no differences in plasma inhibin B or FSH concentrations pretreatment or during TE treatment between physiological conditions. This relationship was also found at the end of the recovery phase. A similar inverse correlation these two groups, and although inhibin B levels at the end of TE treatment were lower in group A (85 Ϯ 12 versus 105 Ϯ has been reported for a group of semen donors . These data therefore support the suggestion that 8 pg/ml), this did not reach statistical significance. However inhibin B concentrations did not then rise in group A, although inhibin B has a role in the physiological regulation of FSH secretion in men. No correlation between inhibin B and LH there was a significant rise in group B, from 105 Ϯ 8 to 134 Ϯ 12 pg/ml (P Ͻ 0.05) after 8 weeks. Plasma FSH was or testosterone was found, but there was a correlation between LH and testosterone concentrations before treatment. There suppressed to undetectable concentrations during TE treatment, but showed a 'rebound' during the recovery phase which was was also no significant direct relationship between plasma inhibin B and sperm concentration before treatment. It has particularly marked in group A. Thus FSH concentrations were higher in group A compared to group B at both 4 and 8 weeks been suggested that inhibin secretion from Sertoli cells is regulated by interaction with germ cells (Pineau et al., 1990 ; recovery: 4.9 Ϯ 2.6 versus 2.4 Ϯ 0.7 IU/l after 4 weeks, and 7.3 Ϯ 1.2 versus 4.6 Ϯ 0.4 IU/l after 8 weeks (P Ͻ 0.005). Carreau, 1995) , and expression of α-and β B -subunit mRNA is maximal at stages of spermatogenesis which are maximally After 24 weeks recovery, both inhibin B concentration and sperm concentration had recovered to pretreatment levels sensitive to FSH (Bhasin et al., 1989) . Inhibin B concentrations are progressively lower in groups of men with increasing ( Figure 2 ). FSH concentration was also similar to pretreatment spermatogenic damage, and are undetectable in men with recovery from an experimentally induced hypogonadotrophic state clearly show the intimate relationship between FSH, azoospermia .
Inhibin B concentrations fell, as expected, during exogenous inhibin B and sperm concentration. The FSH overshoot in the early recovery phase may be due to a relatively faster recovery testosterone suppression of gonadotrophin secretion. FSH concentrations fall to~25% after 7 days, and inhibition of of the gonadotrophs from TE suppression compared to the reestablishment of full Sertoli cell function and inhibin secretion gonadotrophin secretion is complete within 12 weeks of TE administration (Anderson and Wu, 1996) . A statistically leading to suboptimal negative feedback on FSH secretion. FSH returned to the normal pretreatment range later in recovery, significant decline in inhibin B was detectable only 4 days after the first TE injection, and there was a rapid decline over as previously described (Handelsman et al., 1995) , at which time the inverse relationship between FSH and inhibin B was the first 12 weeks of TE treatment. The time-courses of decline in inhibin B and sperm concentration were similar, with an re-established. Measurement of the specific dimeric form inhibin B therefore appears to allow the demonstration of initial rapid fall in both markers over the first 12 weeks followed by a second phase of continuing but slower decline, physiological relationships underlying the previously described differences in FSH concentration, not explained by immunoinhibin B concentrations eventually falling to 30% of pretreatment concentrations after over 1 year of treatment. A decline reactive inhibin or testosterone concentrations. These data provide further evidence to support the postulated role of in inhibin B concentations in normal men during combined TE and levonorgestrel treatment has also been reported inhibin B in the hypothalamo-pituitary-testicular axis. Incomplete suppression of spermatogenesis has been (Anawalt et al., 1996) , the degree of decline in inhibin B being similar to that reported here, although dynamic changes reported with all hormonal methods thus far tested, but the exact basis for this heterogeneity remains unclear. We have during steroid suppression and the recovery phase were not demonstrated. It is thus possible to infer that~70% of plasma previously demonstrated differences in androgen metabolism between azoospermic and oligozoospermic responders (Anderinhibin B is gonadotrophin-dependent, which is in striking similarity to the finding that men with idiopathic hypogonadoson et al., 1996) , which were apparent during TE treatment but not before treatment. Despite the differences in inhibin B trophic hypogonadism have inhibin B concentrations 25-30% of normal (Anawalt et al., 1996; Nachtigall et al., 1996) . A during the recovery phase, inhibin B concentrations pretreatment and during TE treatment did not segregate the rapid from significant proportion of plasma inhibin B (~25%) appears to be gonadotrophin-independent, which is only abolished in the the slow responders. Measurement of plasma inhibin B does not therefore appear to be of value in predicting the spermatogenic presence of primary testicular disease, where inhibin B is undetectable . Inhibin is also secreted response to sex steroid administration.
In conclusion, these results support the hypothesis that by Leydig cells (Risbridger et al., 1989) , but it is unlikely that this would constitute a significant source in the absence of plasma inhibin B is involved in the physiological control of FSH secretion in men. Inhibin B concentrations were also LH. The continuing slow decline in inhibin B concentration even after complete suppression of gonadotrophin secretion correlated with the rate of recovery of spermatogenesis following prolonged suppression, at which time an inverse relationand achieving azoospermia may reflect a continuing change in the interaction between Sertoli cells and the germ cell ship to FSH was also found. Inhibin B is therefore an important additional marker of reproductive function in men. population (Carreau, 1995) .
During recovery from spermatogenic suppression on stopping TE, sperm concentration, inhibin B and FSH all increased towards the pretreatment range. The rates of recovery of
